News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Jamie Stewart, PharmD Candidate

Articles by Jamie Stewart, PharmD Candidate

Molecular model of pembrolizumab | Image Credit: © Dr_Microbe - stock.adobe.com

Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy

ByZachery Halford, PharmD, BCOP, BCPPS,Jamie Stewart, PharmD Candidate,George DeMaagd, PharmD, BCPS,Gregory Franz, MD, MPH

February 19th 2026

Pembrolizumab in adjuvant NSCLC therapy can trigger central adrenal insufficiency with vague fatigue, nausea, and hyponatremia.

Latest Updated Articles

Pembrolizumab-Induced Adrenal Insufficiency: Recognizing and Managing a Diagnostic Challenge in Adjuvant NSCLC Therapy
February 19th 2026

Trending on Pharmacy Times

Overcoming Barriers to Kidney-Protective Therapy

Why Blood Pressure Won't Budge—and How Pharmacists Help

Night Shift Work, Chronic Insomnia Nearly Triple Long-COVID Risk, Study Finds

FDA Grants Fast Track Designation to Safusidenib for IDH1-Mutant Glioma

Biosimilars: A Guide for Pharmacists